The head of the Oxford Vaccine Organization, which co-developed the AstraZeneca coronavirus vaccine, said that there is no connection between the AstraZeneca vaccine injection and blood clotting.
Principal Investigator of Oxford Vaccine Trial Andrew Pollard: “There is a lot of reassuring evidence that there is no increase in thrombosis in the UK. So far, most European doses (AstraZeneca) have been injected in the UK. “
The European Medicines Agency (EMA), which is currently reviewing the thrombotic event, said that the benefits of the vaccine continue to exceed the risk of contracting coronary disease. EMA said that as of March 10, of the nearly 5 million people using the AstraZeneca vaccine across Europe, only 30 reported thrombosis.